当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › European Journal of Clinical Pharmacology杂志
European Journal of Clinical Pharmacology
基本信息
期刊名称 European Journal of Clinical Pharmacology
EUR J CLIN PHARMACOL
期刊ISSN 0031-6970
期刊官方网站 https://www.springer.com/228
是否OA No
出版商 Springer Verlag
出版周期 Monthly
文章处理费 登录后查看
始发年份 1968
年文章数 153
影响因子 2.4(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PHARMACOLOGY & PHARMACY 药学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 5.4 0.727 0.990
Medicine
Pharmacology (medical)
92/272 66%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
142/313 54%
补充信息
自引率 4.2%
H-index 99
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0031-6970%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/ejcl
收稿范围
The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves

a compound that is interesting and new in some basic or fundamental way, or
methods that are original in some basic sense, or
a highly unexpected outcome, or
conclusions that are scientifically novel in some basic or fundamental sense.
Straightforward descriptive data in drug utilization will only be considered if more than one geographical area is studied and if a scientific hypothesis is tested or an intervention carried out. Descriptive data in drug utilization can however be quite useful in a more local setting. Again, if conceptually new methods, analysis, or ways of reasoning are involved, this would elicit greater interest from the international scientific community. In such a case, we would welcome submission to the EJCP and evaluate the paper according to standard procedures.

The Journal also accepts review articles on various topics related to drug action in man. Debate on controversial issues is also encouraged, usually in the form of a letter to the editor that comments on a paper published in the Journal. Case reports on new findings or a new understanding of a mechanism of action should usually also be submitted in the form of a letter to the editor.
收录体裁
投稿指南 https://link.springer.com/journal/228/submission-guidelines
投稿模板
参考文献格式
编辑信息

Coordinating Editor

Rune Dahlqvist
Division of Clinical Pharmacology
University Hospital
90185 Umeå
Sweden

E-mail: Rune.Dahlqvist@pharm.umu.se

Managing Editors 
Uwe Fuhr, Cologne
Emilio J. Sanz, La Laguna
David J.P. Williams, Dublin
Markus Zeitlinger, Vienna

Reviews Editor
Uwe Fuhr, Cologne

Advisory Editors
Karel Allegaert, Leuven 
Janne Backman, Helsinki 
Julio R. Benítez, Badajoz
Joseph S. Bertino Jr, Albany
Maurizio Bonati, Milan
Ylva Böttiger, Huddinge
Alasdair M. Breckenridge, Liverpool
Ingolf Cascorbi, Kiel
Imtiaz Choonara, Derby
Balram Chowbay, Singapore
Fan K. Chung, London
Uwe Christians, Denver
Marja-Liisa Dahl, Stockholm

Rafael Dal-Ré, Madrid
Vita Dolzan, Ljubljana
Johan Fastbom, Stockholm
Robin E. Ferner, Birmingham
Alberg Figueras, Barcelona
Sarah Foley, Cork
Sebstian Frechen, Köln
Takahisa Furuta, Hamamatsu
Andrea Gaedigk, Kansas City
Silvio Garattini, Milan
Walter E. Haefeli, Heidelberg
Staffan Hägg, Linköping
Job Harenberg, Mannheim
Martin Hellmich, Köln
Georg Hempel, Münster
Martin Henriksson, Linköping
Christoph Hiemke, Mainz
Nick Holford, Auckland
Kalle Hoppu, Helsinki
Alexander Jetter, Zurich
Frieder Keller, Ulm
Stephan Krähenbühl, Basel
Joan R. Laporte, Barcelona
Andreas Lindauer, Oss
Jörn Lötsch, Frankfurt
Arduino A. Mangoni, Bedford Park
Patricia McGettigan, London
Juan Merlo, Malmö 
John Miners, Adelaide
Klaus Mörike, Tübingen
Nicola Montanaro, Bologna
Jean-Louis Montastruc, Toulouse
Nicholas Moore, Bordeaux
Domenico Motola, Bologna
Pertti J. Neuvonen, Helsinki
Hedvig M.E. Nordeng, Oslo
Stefan Oswald, Greifswald
Roberto Raschetti, Roma
Christoph Ritter, Greifswald
Cristín Ryan, Dublin
Laura J. Sahm, Cork
Jörn Schneede, Umeå
Folke Sjöqvist, Huddinge
Olav Spigset, Trondheim
Edoardo Spina, Messina
Julia C. Stingl, Bonn
John Stinson, Crumblin
J.J. Swen, Leiden
Petra Thürmann, Wuppertal
Dietmar Trenk, Bad Krozingen
Ellen Vinge, Lund
Susanna M. Wallerstedt, Gothenburg
Tom Walley, Liverpool
Matthew Walters, Glasgow
William S. Waring, York
Martin Wehling, Mannheim
Björn Wettermark, Stockholm
Nick J. White, Oxford
Ken W. Woodhouse, Cardiff
Ümit Yasar, Ankara
Hong-Hao Zhou, Changsha


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug